WEST PHARMACEUTICAL SERVICES, INC. Shareholders' Equity
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Shareholders' Equity of $2.99 billion as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-23
- 2026-06-30: Stockholders' Equity Attributable to Parent $2.99B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.99B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.18B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.05B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $2.99B 10-Q · filed 2026-07-23 |
| 2026-03-31 | $2.99B 10-Q · filed 2026-07-23 |
| 2025-12-31 | $3.18B 10-Q · filed 2026-07-23 |
| 2025-09-30 | $3.05B 10-Q · filed 2025-10-23 |
| 2025-06-30 | $2.93B 10-Q · filed 2026-07-23 |
| 2025-03-31 | $2.68B 10-Q · filed 2026-07-23 |
| 2024-12-31 | $2.68B 10-Q · filed 2026-07-23 |
| 2024-09-30 | $2.75B 10-Q · filed 2025-10-23 |
| 2024-06-30 | $2.58B 10-Q · filed 2025-10-23 |
| 2024-03-31 | $2.68B 10-Q · filed 2025-10-23 |
| 2023-12-31 | $2.88B 10-K · filed 2026-02-17 |
| 2023-09-30 | $2.87B 10-Q · filed 2024-10-24 |
| 2023-06-30 | $2.75B 10-Q · filed 2024-10-24 |
| 2023-03-31 | $2.78B 10-Q · filed 2024-10-24 |
| 2022-12-31 | $2.68B 10-K · filed 2026-02-17 |
| 2022-09-30 | $2.47B 10-Q · filed 2023-10-26 |
| 2022-06-30 | $2.42B 10-Q · filed 2023-10-26 |
| 2022-03-31 | $2.33B 10-Q · filed 2023-10-26 |
| 2021-12-31 | $2.34B 10-K · filed 2025-02-18 |
| 2021-09-30 | $2.20B 10-Q · filed 2022-10-27 |
| 2021-06-30 | $2.03B 10-Q · filed 2022-10-27 |
| 2021-03-31 | $1.83B 10-Q · filed 2022-10-27 |
| 2020-12-31 | $1.85B 10-K · filed 2024-02-20 |
| 2020-09-30 | $1.72B 10-Q · filed 2021-10-28 |
| 2020-06-30 | $1.61B 10-Q · filed 2021-10-28 |
| 2020-03-31 | $1.49B 10-Q · filed 2021-10-28 |
| 2019-12-31 | $1.57B 10-K · filed 2023-02-21 |
| 2019-09-30 | $1.49B 10-Q · filed 2020-10-23 |
| 2019-06-30 | $1.45B 10-Q · filed 2020-10-23 |
| 2019-03-31 | $1.37B 10-Q · filed 2020-10-23 |
| 2018-12-31 | $1.40B 10-K · filed 2022-02-22 |
| 2017-12-31 | $1.28B 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |